The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, BioLife Solutions's share price is $17.53.
BioLife Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.28. Hence, BioLife Solutions's PS Ratio for today is 5.34.
The historical rank and industry rank for BioLife Solutions's PS Ratio or its related term are showing as below:
BLFS'
s PS Ratio Range Over the Past 10 Years
Min: 1.15 Med: 5.88 Max: 26.69
Current: 5.36
During the past 13 years, BioLife Solutions's highest PS Ratio was 26.69. The lowest was 1.15. And the median was 5.88.
BLFS's PS Ratio is ranked worse than 65.55% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 3.19
vs BLFS: 5.36
BioLife Solutions Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of BioLife Solutions was -11.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 23.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 26.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 17.60% per year.
During the past 13 years, BioLife Solutions's highest 3-Year average Revenue per Share Growth Rate was 416.20% per year. The lowest was -49.50% per year. And the median was 11.90% per year.
Back to Basics: PS Ratio
BioLife Solutions PS Ratio Historical Data
The historical data trend for BioLife Solutions's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioLife Solutions's PS Ratio
For the Medical Instruments & Supplies subindustry, BioLife Solutions's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioLife Solutions's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's PS Ratio distribution charts can be found below:
* The bar in red indicates where BioLife Solutions's PS Ratio falls into.
BioLife Solutions PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
BioLife Solutions's Share Price of today is $17.53. BioLife Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.28.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
BioLife Solutions PS Ratio Related Terms
Thank you for viewing the detailed overview of BioLife Solutions's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
BioLife Solutions (BioLife Solutions) Business Description
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BLFS has been successfully added to your 